SCHEMBL3508445

SCHEMBL3508445

C/C=C/CCCCCCCC=O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.61
TRPV1 Q8NER1 2/20 0.61
TSHR P16473 2/20 0.55
HIF1A Q16665 1/20 0.47
MAPT P10636 3/20 0.38
TERT O14746 3/20 0.37
PTPN1 P18031 3/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2C19 P33261 2/20 0.37
BLM P54132 2/20 0.37
HSD17B10 Q99714 2/20 0.37
FABP4 P15090 2/20 0.37
F7 P08709 2/20 0.37
F3 P13726 2/20 0.37
PPARG P37231 2/20 0.37
KMT2A Q03164 2/20 0.37
PPARD Q03181 2/20 0.37
PPARA Q07869 2/20 0.37
GMNN O75496 1/20 0.37
USP2 O75604 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13287169 1.00 FAAH (0.61) FAAHTRPV1TSHRHIF1AMAPT
SCHEMBL20471152 1.00 FAAH (0.61) FAAHTRPV1TSHRHIF1AMAPT
SCHEMBL20178755 1.00 FAAH (0.61) FAAHTRPV1TSHRHIF1AMAPT
SCHEMBL9407137 1.00 FAAH (0.61) FAAHTRPV1TSHRHIF1AMAPT
SCHEMBL18837271 1.00 FAAH (0.61) FAAHTRPV1TSHRHIF1AMAPT
SCHEMBL11607725 1.00 FAAH (0.61) FAAHTRPV1TSHRHIF1AMAPT
SCHEMBL2162605 1.00 FAAH (0.61) FAAHTRPV1TSHRHIF1AMAPT
SCHEMBL9407139 1.00 FAAH (0.61) FAAHTRPV1TSHRHIF1AMAPT
SCHEMBL18837270 1.00 FAAH (0.61) FAAHTRPV1TSHRHIF1AMAPT
SCHEMBL8050706 1.00 FAAH (0.61) FAAHTRPV1TSHRHIF1AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 467 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12589377-B2 Encapsulated composition comprising core-shell microcapsules and process for its preparation GIVAUDAN SA (CH) 2026-03-31 US claimed
EP-4711010-A2 PRO-PERFUME COMPOSITIONS Firmenich SA (CH) 2026-03-18 EP claimed
US-12559703-B2 Fragrance composition GIVAUDAN SA (CH) 2026-02-24 US claimed
WO-2025202258-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2025-10-02 WO claimed
US-12421475-B2 High performing, high impact bloom accord with a top, medium, and base note mixture INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2025-09-23 US claimed
EP-4608360-A1 ANTI-DANDRUFF COMPOSITIONS Firmenich SA (CH) 2025-09-03 EP claimed
EP-4581114-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS Novozymes A/S (DK) 2025-07-09 EP claimed
EP-3325588-B1 PERFUME COMPOSITIONS GIVAUDAN SA (CH) 2025-04-16 EP claimed
CN-119698458-A Improvements in or relating to organic compounds improvements relating to organic compounds 诺维信公司 2025-03-25 CN claimed
EP-4514477-A1 FRAGRANCE COMPOSITIONS HAVING LONG-LASTING TRAIL PERFORMANCE Firmenich SA (CH) 2025-03-05 EP claimed
EP-4120991-A1 CONSUMER PRODUCT COMPRISING A PLURALITY OF MICROCAPSULES DEFINED BY THE MEAN TOTAL SURFACE AREA Givaudan SA (CH) 2023-01-25 EP claimed
CN-115551986-A Fragrance composition 奇华顿股份有限公司 2022-12-30 CN claimed
CN-109689848-B Fragrance composition 奇华顿股份有限公司 2022-12-23 CN claimed
CN-115297822-A Consumer product comprising a plurality of microcapsules defined by an average total surface area 奇华顿股份有限公司 2022-11-04 CN claimed
WO-2022214636-A1 FRAGRANCE COMPOSITION GIVAUDAN SA (CH) 2022-10-13 WO claimed
WO-2022175314-A1 IMPROVEMENT IN OR RELATING TO ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2022-08-25 WO claimed
US-11364184-B2 Perfume compositions GIVAUDAN SA (CH) 2022-06-21 US claimed
US-11326126-B2 High performing, high impact bloom accord INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2022-05-10 US claimed
US-20220064191-A1 SILICONE COMPOUNDS PROCTER & GAMBLE (US) 2022-03-03 US claimed
WO-2022017888-A1 SOAP COMPOSITION FIRMENICH SA (CH) 2022-01-27 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12589377-B2 Encapsulated composition comprising core-shell microcapsules and process for its preparation CUTA, EXOC1, EXOSC10 FAAH 667/4885TRPV1 3104/4885TSHR 2858/4885
US-12559703-B2 Fragrance composition DHCR24, OPRD1, OR10J3 FAAH 55/4885TRPV1 32/4885TSHR 3559/4885
US-20220064191-A1 SILICONE COMPOUNDS SMCHD1, SRI, SMS FAAH 3791/4885TRPV1 3889/4885TSHR 3842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.